Panic disorder and chest pain: Mechanisms, morbidity, and management

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 4, Issue 2, 2002, Pages 54-62

  Huffman, Jeff C ^a,b   Pollack, Mark H ^a   Stern, Theodore A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0344386760     PISSN: 15235998     EISSN: None     Source Type: Journal    
DOI: 10.4088/pcc.v04n0203     Document Type: Article

References (111)

1. Simon NM, Pollack MH. The current status of the treatment of panic disorder: pharmacotherapy and cognitive-behavioral therapy. Psychiatr Ann 2000;30:689-696
2. Myers JK, Weixsmann MM, Tischler GL. et al Six-month prevalence of psychiatric disorders in three communities: 1980-1982. Arch Gen Psychiatry 1984;41:959-967
3. Weissmann MM. Merikangas KR. The epidemiology of anxiety and panic disorders: an update. J Clin Psychiatry 1986;47(suppl 6): 11-17
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington, DC: American Psychiatric Press; 1994;397-403
5. Bowen R. South M, Hawkes J. Mood swings in patients with panic disorder. Can J Psychiatry 1994;39:91-94
6. Savino M, Perugi G, Sirnonini E, et al. Affective cornorbidity in panic disorder: is there a bipolar connection? J Affect Disord 1993;28:155-163
7. Karajgi B, Rifkin A, Doddi S, et al. The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. Arn J Psychiatry 1990;147:200-201
8. Kaplan DS, Masand PS, Gupta S. The relationship of irritable bowel syndrome (IBS) and panic disorder. Ann Clin Psychiatry 1996;8:81-88
9. Lydiard RB, Greenwald S. Weissman MM. et al. Panic disorder and gastrointestinal symptoms: findings from the NIMM Epidemiologie Catchment Area project. Am J Psychiatry 1994;151:64-70
10. Katon W, Vilaliano PP. Russo J, et al. Panic disorder: epidemiology in primary care. J Fam Prac 1986;23:233-239
11. Klerman GL, Weissman MM. Ouellette R, et al. Panic attacks in the community: social morbidity and health care utilization. JAMA 1991;265: 742-746
12. Edlund MJ, Swann AC. The economic and social costs of panic disorder. Hosp Community Psychiatry 1987;38:1277-1288
13. Markowitz J. Weissman MM, Oullette R, el al. Quality of life in panic disorder. Arch Gen Psychiatry 1989;46:984-992
14. Katon W, Panic disorder: relationship to high medical utilization, unexplained physical symptoms, and medical costs. J Clin Psychiatry 1996;57 (suppl 10):11-18
15. Katon W. Panic disorder and somatiwition: a review of 55 cases. Am J Med 1984;77:101-106
16. Barlow DB. Verrnilyea J. Blanchard EB, et al. The phenomenon of panic. J Abnorm Psychol 1985;94:320-328
17. Fleet RP. DuPuis G, Marchand A, el al. Panic disorder in emergency chest pain patients: prevalence, comorbidity. suicidal ideation, and physician recognition, Am J Med 1996;101:371-380
18. Yingling KW, Wulsin LR. Arnold LM, el al. Estimated prevalences of panic disorder and depression among consecutive patients seen in an emergency department with acute chest pain. J Gen Int Med 1993;8: 231-235
19. Fleet RP, Dupuis G, Marchand A, et al. Delecling panic disorder in emergency department chest pain patients: a validated model lo improve recognition. Ann Bchav Med 1997;19:124-131
20. Katon W, Hall ML, Russo J, el al. Chest pain: relationship of psychiatric illness to coronary arteriographic results. Am J Med 1988;84:1-9
21. Cormier LE. Katon W. Russo. et al. Chest pain with negative diagnostic studies: relationship to psychiatric illness. J Nerv Ment Dis 1988;176: 351-358
22. 2 measurement and psychiatric scores. Eur Heart J 1991;12(suppl):l03-108
23. Potts AG, Bass C. Chest pain with normal coronary arteries: psychological aspects. In: Kaski JC, ed. Chest Pain With Normal Coronary Angiograms. Norwell, Mass: Kluwer Academic Publishers: 1999;13-32
24. Young LD. The effect of psychological and environmental Stressors on peristaltic esophageal contractions in healthy volunteers. Psychophysiology 1987;24:132-141
25. Gross RT, Collins FC. On the relationship between anxiety and pain: a methodological confounding. Clin Psychol Rev 1981; 1:375-386
26. Cinciripini PM, Williamson D, Epslein LH. The behavioral treatment of migraine headaches. In: Taylor CB, Ferguson J, eds. Comprehensive Textbook of Behavioral Medicine. New York, NY: SP Medical and Scientific Books; 1993;207-227
27. Fordyce WE. Behavioral Methods for Chronic Pain and Illness. St. Louis, Mo: Mosby: 1976;24-28
28. Yasue H, Nagao M. Omote S, et al. Coronary arterial spasm and Prinzmetal's variant of angina induced by hyperventilation and Tris-buffer infusion. Circulation 1978;58:56-62
29. Rasmussen K, Ravnshaek J. Funch-Jensen P. Esophageal spasm in patients with coronary artery spasm. Lancet 1986;1:174-176
30. Katon WJ. Chest pain, cardiac disease, and panic disorder. J Clin Psychiatry 1990;51(suppl 5):27-30
31. Bohlen HG. Arteriolar closure mediated by hyper-responsiveness to norepinephrinc in hypertensive rats. Am J Physiol 1979;236:H157-H164
32. Katon W. Roy-Byrne PP. Panic disorder in the medically ill. J Clin Psychiatry 1989;50:299-302
33. Chauhan A. Mullins PA. Taylor G. et al. Effect of hyperyentilalion and mental stress on coronary blood flow in syndrome X. Br Heart J 1993;69: 516-524
34. Svensson TH. Peripheral, autonomie regulation of the locus coeruleus neurons in the brain: putative implications for psychiatric illness and psychopharmacology. Psychopharmacology (Bcrl) 1987;92:l-7
35. Zaubler TS. Katon W. Panic disorder and medical comorbidity: a review of the medical and psychiatric literature. Bull Menninger Clin 1996;60 (suppl 2A):A12-A38
36. Aronson PR. Hyperventilation syndrome: a comparative study of the effects of tranquilizers and a sedative upon the electrocardiogram. Clin Pharmaeol Ther 1964;5:553-562
37. Biberman L, Sarma RN, Surawicz B. T-wave abnormalities during hyperventilation and isoproterenol infusion. Am Heart J 1971;81:166-174
38. Jacobs WF, Battle WE, Ronan JA. False-positive ST-Twave changes secondary to hyperventilation and exercise: a cineangiographic correlation. Ann Intern Med 1974;81:479-482
39. Lary D, Goldschlager N. Electrocardiogram changes during hyperventilation resembling myocardial ischemia in patients with normal coronary arteriograms. Am Heart J 1974;87:383-390
40. McHenry PL. Cogan OJ, Elliott WC. et al. False positive ECG response to exercise secondary to hyperventilation: cineangiographic correlation. Am Heart J 1970;79:683-687
41. Wasserburger RH, Lorenz TH. The effect of hyperventilation and ProBanthine on isolated RS-T segment T-wave abnormalities. Am Heart J 1956;51:666-669
42. Wasserberger RH, Siebecker KL. Lewis WC. The effect of hyperventilation on the normal adult electrocardiogram. Circulation 1956; 13: 850-854
43. Wenkos MH, Logue RB. Unstable T waves in leads II and III in persons with neurocirculatory asthenia. Am Heart J 1946;31:711-713
44. Thompson WP. The electrocardiogram in the hyperventilation syndrome. Am Heart J 1943;25:372-379
45. Scherf D, Schlachrnan M. The electrocardiographie changes caused by hyperventilation. Am J Med Sci 1947;213:342-347
46. Yasue H, Omote S. Takizawa A, et al. Comparison of coronary arteriographic findings during angina pectoris associated with S-T elevation or depression. Arn J Cardiol 1981;47:539-546
47. Mortensen SA. Vilhelmson R, Sande E. Prinzmetal's variant of angina (PVA): circadian variation in response to hyperventilation. Ada Med ScandSuppl 1981;644:38-41
48. Neill WA. Hattenhauer M. Impairment of rnyocardial oxygen supply due to hyperventilation. Circulation 1975;52:854-858
49. Balon R. Ortiz A, Pohl R, et al. Heart rate and blood pressure duringplacebo-associated panic attacks. Psychosom Med 1988;50:434-438
50. Freedman RR, Ianni P. Ettegui E, et al. Ambulatory monitoring of panic disorder. Arch Gen Psychiatry 1985;42:244-248
51. White WB. Baker CH. Episodic hypertension secondary to panic disorder. Arch Int Med 1986;146:1129-1130
52. Cannon RO, Watson RM, Rosing DR. el al. Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol 1983; 1:1359-1373
53. Roy-Byrne PP. Schmidt P, Cannon RO, et al. Microvascular angina and panic disorder. Int J Psychiatry Med 1989;19:315-325
54. Kahn JP, Drusin RE, Klein DF. Idiopathic cardiomyopathy and panic disorder: clinical association in cardiac transplant candidates. Am J Psychiatry 1987;144:1327-1330
55. Kahn JP, Gonnan JM, King DL. et al. Cardiac left ventricular hypertrophy and chamber dilatation in panic disorder patients: implications for idiopathic dilated cardiomyopathy. Psychiatry Res 1990;321:55-61
56. Van Vieil PD, Burchell HB, Titus JL. Focal myocarditis associated with pheochromocyloma. N Engl J Med 1966;274: 1102-1108
57. Gillette PC. Smith RT, Garson A. et al. Chronic supraventricular tachycardia: a curable cause of congestive cardiomyopathy. JAMA 1985;253: 391-392
58. Kawachi I, Sparrow D, Vokonas PS. el al. Symploms of anxiety and risk of coronary heart disease: the Normative Aging Study. Circulation 1994;90: 2225-2229
59. Haines AP, Imeson JD. Meade TW. Phobic anxiety and ischaemic heart disease. Br Med J 1987;295:297-299
60. Kawachi I, Colditz GA, Acherio A, et al. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994;89: 1992-1997
61. Coryell W. Panic disorder and mortality. Psychialr Clin North Am 1988;2: 433-440
62. Coryell W, Noyes R, Clancy J. Excess mortality in panic disorder: a comparison with primaiy unipolar depression. Arch Gen Psychiatry 1982; 139: 701-703
63. Coryell W, Moves R. House JD. Mortality among outpatients with anxiety disorders. Am J Psychiatry 1986;143:508-510
64. Weissmann MM, Markowilz JS, Ouellette MD, et al. Panic disorder and cardiovaseular/cerebrovaseular problems: results from a community survey. Am J Psychiatry 1990;147:1504-1508
65. Van Ravenswaaij-Arts CA, Kollee LA, Hopman JW. et al. Heart rate variability. Ann Intern Med 1993;119:436-447
66. Myerberg RJ. Kessler KM, Caslellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993; 119:1187-1197
67. Odemuyiwa O, Matik M, Farrell T, et al. Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events, and sudden death after acute myocardiat infarction. Am J Cardiol 1991;68:434-439
68. Kawachi I, Sparrow D. Vokonas PS. Decreased heart rate variability in men with phobic anxiety (data from the Normative Aging Sludy). Am J Cardiol 1995;175:882-885
69. Yeragani VK. Rohl R, Berger R, et al. Decreased heart rate variability in panic disorder patients: a study of power-spectral analysis of heart rate. Psychiatry Res 1993;46:89-103
70. Yeragani VK, Rohl R, Srinivasan K, et al. Effects of isoproterenol infusions on heart rate variability in patients with panic disorder. Psychiatry Res 1995;56:289-293
71. Klein E, Cnaai E. Harel T, et al. Altered heart rate variability in panic disorder patients. Biol Psychiatry 1995;37:18-24
72. Asmundson GJG, Stein MB. Vagal attenuation in panic disorder: an assessment of parasympathelic nervous system function and subjective reactivity to respiratory manipulations. Psychosom Med 1994;56:187-193
73. Elect RP, Beitman BD. Cardiovascular death from panic disorder and panic-like anxiety: a critical review of the literature. J Psychsom Res 1998; 44:71-80
74. Hay ward C. Taylor CB, Roth WT, et al. Plasma lipid levels in patients with panic disorder or agoraphobia. Am J Psychiatry 1989;146:917-919
75. Katerndahl DA, Realini JP. Where do panic attack sufferers seek care? J Fam Pract 1995;40:237-243
76. Sheehan DV. Ballenger JC, Jacobsen G. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry 1980;37:51-59
77. Eaton WW, Kessler LG, eds. Epidemiologie Field Methods in Psychiatry:The NIMH Epidemiologie Catchment Area Program. Orlando, Fla: Academic Press; 1985;20-45
78. Regier DA, Myers JK. Kramer M, et al. The NIMH Epidemiologie Catchment Area program: historical context, major objectives, and study population characteristics. Arch Gen Psychiatry 1984;41:934-941
79. Simon GE, VonKorff M. Somatization and psychiatric disorder in the Epidemiologie Catchment Area study. Am J Psychiatry 1991;148:1494-1500
80. Simpson RJ, Kazmierczak T, Power KG. et al. Controlled comparison of patients with panic disorder. Br J Gen Pract 1994;44:352-356
81. Leon AC. Portera L. Weissmann MM. The social costs of panic disorder. BrJ Psychiatry 1995;166(suppl 27): 19-22
82. Katon W. Hollif'ield M, Chapman T, et al. Infrequent panic attacks: psychiatric comorbidity, personality characteristics, and functional disability. J Psychiatr Res 1995;29:121-131
83. Ockene IS. Shay MJ. Alpen JS, et al. Unexplained chest pain in patients with normal coronary arteriograms. N Engl J Med 1980;303:1249-1252
84. Lavey EB, Winkle RA, Continuing disability of patients with chest pain and normal coronary arteriograms. J Chronic Dis 1979;32:191-196
85. Papanicolaou MN. Califf RM, Hlatky MA. et al. Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries. Am J Cardiol 1986;58:1181-1187
86. Beitman BD. Kushner MG, Basha I, et al. Follow-up status of patients with angiographically normal coronary arteries and panic disorder. JAMA 1991;265:1545-1549
87. Jobson KO, Davidson JRT, Lydiard BR. et al. Algorithm for treatment of panic disorder with agoraphobia. Psychopharmacol Bull 1995;31: 483-485
88. Rosenbaum JF, Pollack MH, Fredman SJ. The pharrnacotherapy of panic disorder. In: Rosenbaum JE. Pollack MH, eds. Panic Disorder and Its Treatment. New York, NY: Marcel Dekker; 1998;153-180
89. Pollack MH. Worthington JJ, Otto MW, et al. Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study. Psychopharmacol Bull 1996;32:667-670
90. Cross-National Collaborative Panic Study SPI. Drug treatment of panic disorder: comparative efficacy of alprazolam, imipramine, and placebo. BrJ Psychiatry 1992; 160:191-205
91. Lydiard RB, Morion WA, Emmanuel NP, et al. Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder. Psychophamiacol Bull 1993;29:183-188
92. Zitrin CM, Klein DF, Woerner MG, et al. Treatment of phobias. I: comparison of imipramine hvdrochloride and placebo. Arch Gen Psychiatry 1980;37:63-72
93. Uhlenhuth EH, Matuzas W, Glass RM. Response of panic disorder to fixed doses of alprazolam or imipramine. J Affect Disord 1989;17:261 -270
94. Dunner DL, Ishiki D. Avery DH. et al. Effect of alprazolam and diazepam in anxiety and panic attacks in panic disorder: a controlled study. J Clin Psychiatry 1986;47:458-460
95. Tesar GE, Rosenbaum JF, Pollack MH, et al. Double-blind, placebocontrolled comparison of clonazepam and alprazolam for panic disorder. J Clin Psychiatry 1991;52:69-76
96. Charncy DS, Woods SW. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam. J Clin Psychiatry 1989;50: 418-423
97. Rosenbaum JF, Moroz G, Bowden CL, for the Clonazeparn Panic Disorder Dose-Response Study Group. Clonazeparn in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. J Clin Psychopharmacol 1997;17:390-400
98. Woithington JJ III. Pollack MH. Otto MW, et al. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder. Psychopharmacol Bull 1998;34:199-205
99. Craske MG, Brown TA, Barlow DA. Behavioral treatment of panic disorder: a two-year follow-up. Behav Ther 1991;22:289-304
100. Klosko JS. Barlow DS, Tassarini R, et al. A comparison of alprazolam and behavior therapy in treatment of panic disorder. J Consult Clin Psychol 1990;58:77-84
101. Telch MJ, Lucas JA, Schimdt NB. et al. Group cognitive-behavioral treatment of panic disorder. Behav Res Ther 1993;31:279-287
102. Ost LG, Wesling BE. Applied relaxation vs cognitive behavior therapy in the treatment of panic disorder. Behav Res Ther 1995;33:145-158
103. Ballenger JC, Wheadon DE. Steiner M, et al. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry 1998;155:36-42
104. Tucker P. Adamson P. Miranda R Jr, et al. Paroxetine increases heart rate variability in panic disorder. J Clin Psychopharmacol 1997;17:370-376
105. Nagy LM. Krystal JH, Woods SW. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panicdisorder: 2.5 year naturalistic follow-up. Arch Gen Psychiatry 1989; 46:993-999
106. Noyes R Jr, Borrows GD. Reich JH, et al. Diazepam versus alprazolam for the treatment of panic disorder. J Clin Psychiatry 1996;57:349-355
107. Clark DM, Salkovskis PM. Hackmann A. et al. A comparison of cognitive therapy, applied relaxation, and imiprarnine in the treatment of panic disorder. Br J Psychiatry 1994;164:759-769
108. Fava GA, Zielezny M, Savron G. et al. Long-term effects of behavioural treatment for panic disorder with agoraphobia. BrJ Psychiatry 1995;166: 87-92
109. Gould R. Otto MW, Pollack MH. A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev 1995;15:819-844
110. Beitroati BD. Basha IM, Trombka LH, et al. Alprazolam in the treatment of cardiology patients with atypical chest pain and panic disorder. J Clin Psychopharmacol 1988;8:127-130
111. Wulsin LR, Maddock R, Beitman B. et al. Clonazepam treatment of panic disorder in patients with recurrent chest pain and normal coronary arteries. Int J Psychiatry Med 1999;29:97-105